ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO0262

Bicarbonate Ion Receptor GPR30 and Renal Ischemia-Reperfusion Injury

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Hirose, Hitomi, Department of Ion Signaling and Response, Sakaguchi Laboratory, Keio University School of Medicine, Shinjuku, Tokyo, Japan
  • Gohda, Tomohito, Department of Nephrology, Juntendo University Faculty of Medicine, Bunkyo, Tokyo, Japan
  • Suzuki, Yusuke, Department of Nephrology, Juntendo University Faculty of Medicine, Bunkyo, Tokyo, Japan
  • Jo, Airi, Department of Ion Signaling and Response, Sakaguchi Laboratory, Keio University School of Medicine, Shinjuku, Tokyo, Japan
Background

Renal ischemia-reperfusion (I/R) injury causes acute kidney injury, contributes to renal dysfunction after kidney transplantation, and promotes the progression of chronic kidney disease. Renal I/R also induces marked alterations in pH and ion concentrations. GPR30 is a newly identified bicarbonate-sensing G protein-coupled receptor and elicits cellular responses in a pH-independent manner. This study aims to clarify the involvement of GPR30 in the pathophysiology of renal I/R injury.

Methods

Male C57BL/6 mice were used to establish a unilateral nephrectomy with contralateral renal (I/R) injury model. Mice were sacrificed at 24 hours or 7 days after I/R injury. Blood urea nitrogen (BUN) level was measured at 24 hours and/or 7 days after reperfusion. Histological analyses using Periodic acid-Schiff (PAS) staining was performed to evaluate proximal tubule injury. To analyze GPR30 expression, kidney tissue sections obtained from knock-in mice, in which the GPR30 coding sequence was replaced with the fluorescent protein Venus, were examined using confocal laser microscope. Renal blood flow during and after I/R injury was assessed using laser doppler flowmetry.

Results

BUN levels after renal I/R injury were lower in GPR30-deficient mice than those in control mice. Histological analysis showed prominent recovery of tubular injury in GPR30-deficient mice on day 7 after I/R injury. Venus expression, indicating the localization of GPR30, was observed in renal vessels and a part of renal tubules. Laser doppler flowmetry demonstrated dynamic changes in renal blood flow during and after I/R injury. In GPR30-deficient mice, no significant difference in renal blood flow was observed between baseline and 24 hours after I/R injury, whereas control mice showed a significant reduction in blood flow.

Conclusion

Compared with control mice, GPR30-deficient mice showed significant recovery from tubular injury and milder renal dysfunction following renal I/R injury. Reduced post-reperfusion blood flow mediated by arteriolar GPR30 may contribute to the progression of tubular injury. Our findings indicate that GPR30 is involved in the pathogenesis of renal I/R injury and may be a potential therapeutic target.